Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1 −/− mouse
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Niemann-Pick type C disease is largely attributable to an inactivating mutation of NPC1 protein, which normally aids movement of unesterified cholesterol (C) from the endosomal/lysosomal (E/L) compartment to the cytosolic compartment of cells throughout the body. This defect results in activation of macrophages in many tissues, progressive liver disease, and neurodegeneration. In the npc1 −/− mouse, a model of this disease, the whole-animal C pool expands from 2,082 to 4,925 mg/kg body weight (bw) and the hepatic C pool increases from 132 to 1,485 mg/kg bw between birth and 49 days of age. A single dose of 2-hydroxypropyl-β-cyclodextrin (CYCLO) administered at 7 days of age immediately caused this sequestered C to flow from the lysosomes to the cytosolic pool in many organs, resulting in a marked increase in cholesteryl esters, suppression of C but not fatty acid synthesis, down-regulation of genes controlled by sterol regulatory element 2, and up-regulation of many liver X receptor target genes. There was also decreased expression of proinflammatory proteins in the liver and brain. In the liver, where the rate of C sequestration equaled 79 mg·d −1 ·kg −1 , treatment with CYCLO within 24 h increased C movement out of the E/L compartment from near 0 to 233 mg·d −1 ·kg −1 . By 49 days of age, this single injection of CYCLO resulted in a reduction in whole-body C burden of >900 mg/kg, marked improvement in liver function tests, much less neurodegeneration, and, ultimately, significant prolongation of life. These findings suggest that CYCLO acutely reverses the lysosomal transport defect seen in NPC disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
Niemann-Pick C1 Disease Gene: Homology to Mediators of Cholesterol Homeostasis
Carstea, E. D., Morris, J. A., Coleman, K. G., Loftus, S. K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M. A., Pavan, W. J., Krizman, D. B., et al. (1997) · Science · doi:10.1126/science.277.5323.228 · Cited by 1,293
Cellular Cholesterol Efflux Mediated by Cyclodextrins
Kilsdonk, E. P. C., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17250 · Cited by 890
Identification of HE1 as the Second Gene of Niemann-Pick C Disease
Naureckiene, S., Sleat, D. E., Lackland, H., Fensom, A., Vanier, M. T., Wattiaux, R., Jadot, M., & Lobel, P. (2000) · Science · doi:10.1126/science.290.5500.2298 · Cited by 824
Murine Model of Niemann-Pick C Disease: Mutation in a Cholesterol Homeostasis Gene
Loftus, S. K., Morris, J. A., Carstea, E. D., Gu, J. Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M. A., Tagle, D. A., et al. (1997) · Science · doi:10.1126/science.277.5323.232 · Cited by 801
The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis
Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 759
Self-citationUse of cyclodextrins for manipulating cellular cholesterol content
Christian, A. E., Haynes, M. P., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34940-3 · Cited by 754
Receptor-mediated endocytosis: insights from the lipoprotein receptor system
Brown, M. S., & Goldstein, J. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3330 · Cited by 506
Infante, R. E., Wang, M. L., Radhakrishnan, A., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807328105 · Cited by 491
Cellular Cholesterol Efflux Mediated by Cyclodextrins
Yancey, P. G., Rodrigueza, W. V., Kilsdonk, E. P. C., Stoudt, G. W., Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16026 · Cited by 458
Innerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
Griffin, L. D., Gong, W., Verot, L., & Mellon, S. H. (2004) · Nature Medicine · doi:10.1038/nm1073 · Cited by 395
Neufeld, E. B., Wastney, M., Patel, S., Suresh, S., Cooney, A. M., Dwyer, N. K., Roff, C. F., Ohno, K., Morris, J. A., Carstea, E. D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9627 · Cited by 373
Patterned Purkinje cell degeneration in mouse models of Niemann‐Pick type C disease
Sarna, J. R., Larouche, M., Marzban, H., Sillitoe, R. V., Rancourt, D. E., & Hawkes, R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10522 · Cited by 223
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.
Atger, V. M., de la Llera Moya, M., Stoudt, G. W., Rodrigueza, W. V., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119223 · Cited by 176
Genetic variations and treatments that affect the lifespan of the NPC1 mouse
Liu, B., Li, H., Repa, J. J., Turley, S. D., & Dietschy, J. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700525-jlr200 · Cited by 160
Self-citationDu, H. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1347 · Cited by 153
Repa, J. J., Li, H., Frank-Cannon, T. C., Valasek, M. A., Turley, S. D., Tansey, M. G., & Dietschy, J. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4823-07.2007 · Cited by 148
Self-citationLysosomal cysteine cathepsins: signaling pathways in apoptosis
Stoka, V., Turk, V., & Turk, B. (2007) · bchm · doi:10.1515/bc.2007.064 · Cited by 141
Cholesterol Accumulation and Liver Cell Death in Mice With Niemann-Pick Type C Disease *
Beltroy, E. P., Richardson, J. A., Horton, J. D., Turley, S. D., & Dietschy, J. M. (2005) · Hepatology · doi:10.1002/hep.20868 · Cited by 131
Self-citationIntracellular cholesterol trafficking: role of the NPC1 protein
Blanchette‐Mackie, E. J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00055-x · Cited by 121
Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein
Xie, C., Turley, S. D., Pentchev, P. G., & Dietschy, J. M. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.2.e336 · Cited by 115
Self-citationRegulation of Sterol Transport between Membranes and NPC2
Xu, Z., Farver, W., Kodukula, S., & Storch, J. (2008) · Biochemistry · doi:10.1021/bi801328u · Cited by 95
Xie, C., Turley, S. D., & Dietschy, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11992 · Cited by 92
Self-citationKatz, Y., & Diamond, J. M. (1974) · The Journal of Membrane Biology · doi:10.1007/bf01870174 · Cited by 89
Beltroy, E. P., Liu, B., Dietschy, J. M., & Turley, S. D. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600488-jlr200 · Cited by 61
Self-citationLiu, B., Xie, C., Richardson, J. A., Turley, S. D., & Dietschy, J. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700125-jlr200 · Cited by 42
Self-citationAlternate transcripts expressed in response to diet reflect tissue-specific regulation of ABCA1
Singaraja, R. R., James, E. R., Crim, J. L., Visscher, H., Chatterjee, A., & Hayden, M. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500133-jlr200 · Cited by 25
Research works printed but not linked: 1
- 10.1194/jlr.M700482-JLR200 · DOI
Cited by
Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
Cholesterol metabolism and homeostasis in the brain
Zhang, J., & Liu, Q. (2015) · Protein & Cell · doi:10.1007/s13238-014-0131-3 · Cited by 686
“About 1% of the total cholesterol content exists as esterified form (Bryleva et al., 2010; Liu et al., 2009), it is also called lipid droplets.”
Early steps in steroidogenesis: intracellular cholesterol trafficking
Miller, W. L., & Bose, H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r016675 · Cited by 554
Cholesterol metabolism in neurons and astrocytes
Pfrieger, F. W., & Ungerer, N. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.002 · Cited by 500
Metadata
- Authors
- Liu, B., Turley, S. D., Burns, D. K., Miller, A. M., Repa, J. J., & Dietschy, J. M.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-02-17
- Volume
- 106
- Issue
- 7
- Pages
- 2377-2382
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2065408118
- Cited by
- 377
- References
- 30
- FWCI
- 18.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.